Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait
<p>Abstract</p> <p>Background</p> <p>Ethambutol (EMB) is a first-line drug for the treatment of tuberculosis (TB). Resistance to EMB in <it>Mycobacterium tuberculosis </it>isolates is mediated by mutations in several genes involved in arabinan synthesis nota...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-01-01
|
| Series: | Annals of Clinical Microbiology and Antimicrobials |
| Online Access: | http://www.ann-clinmicrob.com/content/8/1/2 |
| _version_ | 1811260424102871040 |
|---|---|
| author | Ahmad Suhail Jaber Al-Anoud Mokaddas Eiman |
| author_facet | Ahmad Suhail Jaber Al-Anoud Mokaddas Eiman |
| author_sort | Ahmad Suhail |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Ethambutol (EMB) is a first-line drug for the treatment of tuberculosis (TB). Resistance to EMB in <it>Mycobacterium tuberculosis </it>isolates is mediated by mutations in several genes involved in arabinan synthesis notably three <it>emb </it>(arabinosyl transferase) and <it>iniA </it>(isoniazid-inducible) genes. Most epidemiologically unrelated EMB-resistant <it>M. tuberculosis </it>strains contain mutations at <it>embB </it>codons 306, 406 and 497, <it>embC-embA </it>intergenic region (IGR) and <it>iniA </it>codon 501 (<it>iniA501</it>).</p> <p>Objective</p> <p>To develop a more comprehensive molecular screen for EMB-resistance detectioamong epidemiologically unrelated EMB-resistant <it>M. tuberculosis </it>strains previously analyzed for <it>embB </it>codon 306, 406 and 497 mutations by including analysis of mutations at <it>iniA501 </it>and in <it>embC-embA </it>IGR.</p> <p>Methods</p> <p>Fifty consecutive and phenotypically documented EMB-resistant and 25 pansusceptible <it>M. tuberculosis </it>strains isolated from 75 different TB patients over a four-year period in Kuwait were analyzed. Mutations at <it>iniA501 </it>were detected by PCR amplification followed by restriction fragment length polymorphism (RFLP) patterns generated with <it>Hpy </it>99 I. Direct DNA sequencing was used to confirm RFLP results and for detecting mutations in <it>embC-embA </it>IGR.</p> <p>Results</p> <p>Nearly same number of EMB-resistant <it>M. tuberculosis </it>strains were resistant to EMB alone and EMB together with additional resistance to rifampicin and isoniazid (9 of 50, 18% and 11 of 50, 22%, respectively). All the 25 pansusceptible strains contained wild-type sequences at <it>iniA501 </it>and in <it>embC-embA </it>IGR. The analysis of 50 EMB-resistant <it>M. tuberculosis </it>isolates showed that only one strain contained a mutated <it>iniA501 </it>while no mutation was detected in <it>embC-embA </it>IGR in any of the isolate.</p> <p>Conclusion</p> <p>Analysis of <it>iniA501 </it>and <it>embC-embA </it>IGR in epidemiologically unrelated EMB-resistant <it>M. tuberculosis </it>isolates in Kuwait indicate that mutations at these locations occur very infrequently and their inclusion for the development of a comprehensive molecular screen will make only minor contribution towards rapid EMB resistance detection.</p> |
| first_indexed | 2024-04-12T18:47:09Z |
| format | Article |
| id | doaj.art-75a3ca16929948e0bdf0b72e9a3cec5f |
| institution | Directory Open Access Journal |
| issn | 1476-0711 |
| language | English |
| last_indexed | 2024-04-12T18:47:09Z |
| publishDate | 2009-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Annals of Clinical Microbiology and Antimicrobials |
| spelling | doaj.art-75a3ca16929948e0bdf0b72e9a3cec5f2022-12-22T03:20:35ZengBMCAnnals of Clinical Microbiology and Antimicrobials1476-07112009-01-0181210.1186/1476-0711-8-2Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in KuwaitAhmad SuhailJaber Al-AnoudMokaddas Eiman<p>Abstract</p> <p>Background</p> <p>Ethambutol (EMB) is a first-line drug for the treatment of tuberculosis (TB). Resistance to EMB in <it>Mycobacterium tuberculosis </it>isolates is mediated by mutations in several genes involved in arabinan synthesis notably three <it>emb </it>(arabinosyl transferase) and <it>iniA </it>(isoniazid-inducible) genes. Most epidemiologically unrelated EMB-resistant <it>M. tuberculosis </it>strains contain mutations at <it>embB </it>codons 306, 406 and 497, <it>embC-embA </it>intergenic region (IGR) and <it>iniA </it>codon 501 (<it>iniA501</it>).</p> <p>Objective</p> <p>To develop a more comprehensive molecular screen for EMB-resistance detectioamong epidemiologically unrelated EMB-resistant <it>M. tuberculosis </it>strains previously analyzed for <it>embB </it>codon 306, 406 and 497 mutations by including analysis of mutations at <it>iniA501 </it>and in <it>embC-embA </it>IGR.</p> <p>Methods</p> <p>Fifty consecutive and phenotypically documented EMB-resistant and 25 pansusceptible <it>M. tuberculosis </it>strains isolated from 75 different TB patients over a four-year period in Kuwait were analyzed. Mutations at <it>iniA501 </it>were detected by PCR amplification followed by restriction fragment length polymorphism (RFLP) patterns generated with <it>Hpy </it>99 I. Direct DNA sequencing was used to confirm RFLP results and for detecting mutations in <it>embC-embA </it>IGR.</p> <p>Results</p> <p>Nearly same number of EMB-resistant <it>M. tuberculosis </it>strains were resistant to EMB alone and EMB together with additional resistance to rifampicin and isoniazid (9 of 50, 18% and 11 of 50, 22%, respectively). All the 25 pansusceptible strains contained wild-type sequences at <it>iniA501 </it>and in <it>embC-embA </it>IGR. The analysis of 50 EMB-resistant <it>M. tuberculosis </it>isolates showed that only one strain contained a mutated <it>iniA501 </it>while no mutation was detected in <it>embC-embA </it>IGR in any of the isolate.</p> <p>Conclusion</p> <p>Analysis of <it>iniA501 </it>and <it>embC-embA </it>IGR in epidemiologically unrelated EMB-resistant <it>M. tuberculosis </it>isolates in Kuwait indicate that mutations at these locations occur very infrequently and their inclusion for the development of a comprehensive molecular screen will make only minor contribution towards rapid EMB resistance detection.</p>http://www.ann-clinmicrob.com/content/8/1/2 |
| spellingShingle | Ahmad Suhail Jaber Al-Anoud Mokaddas Eiman Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait Annals of Clinical Microbiology and Antimicrobials |
| title | Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait |
| title_full | Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait |
| title_fullStr | Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait |
| title_full_unstemmed | Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait |
| title_short | Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait |
| title_sort | minor contribution of mutations at it inia it codon 501 and it embc emba it intergenic region in ethambutol resistant clinical it mycobacterium tuberculosis it isolates in kuwait |
| url | http://www.ann-clinmicrob.com/content/8/1/2 |
| work_keys_str_mv | AT ahmadsuhail minorcontributionofmutationsatitiniaitcodon501anditembcembaitintergenicregioninethambutolresistantclinicalitmycobacteriumtuberculosisitisolatesinkuwait AT jaberalanoud minorcontributionofmutationsatitiniaitcodon501anditembcembaitintergenicregioninethambutolresistantclinicalitmycobacteriumtuberculosisitisolatesinkuwait AT mokaddaseiman minorcontributionofmutationsatitiniaitcodon501anditembcembaitintergenicregioninethambutolresistantclinicalitmycobacteriumtuberculosisitisolatesinkuwait |